CD8A and myeloid sarcoma: Although these results support a role for EBV-infected B cells as local APC sustaining a detrimental antiviral immune response (Figure 1B), their presence in the MS brain at end-stage disease indicates that the CD8 T cell response fails to get rid of the infection.